
University of Galway projects secure €300,000 in ERC grants
University of Galway projects secure €300,000 in ERC grants
- Two projects from the University of Galway received Proof of Concept grants from the European Research Council.
- The funded projects focus on innovative technology in 3D design and healthcare for pain relief.
- These grants illustrate a successful connection between academic research and practical applications.
Story
In Ireland, two projects from the University of Galway recently succeeded in securing Proof of Concept (PoC) grants from the European Research Council (ERC). This occurred in the second funding round for 2025 and brought the total of winning projects in Ireland for that year to four. Each selected project will receive €150,000 to investigate their commercial viability. The ERC’s PoC funding initiative currently has an overall budget of €45 million and supports researchers in exploring the practical applications of their scientific discoveries. A total of 136 projects were approved in this final funding call for the year. Most of the winning projects are based in Germany, Spain, Italy, and the UK, reflecting a diverse European research landscape fostered by ERC funding. The specific projects awarded from the University of Galway focus on groundbreaking advancements in technology and healthcare, demonstrating a significant relationship between academic research and real-world implications. One project involves a 3D designing technology inspired by nature, which has the potential to revolutionize complex and lightweight part creation, minimizing material waste. The second project is known as Uro-Lieve and aims to provide a minimally invasive approach to alleviate pain from interstitial cystitis, a painful bladder condition, by using a biodegradable capsaicin hydrogel. These grants signify not just academic success but a bridge between scientific discovery and marketable innovation, emphasizing the importance of translating research into opportunities that can benefit society and industry alike. Vaughan, the lead researcher on the 3D designing project, expressed optimism about the new technology's ability to tailor production-ready designs, saying it could foster innovation and reduce costs. O'Halloran, the principal investigator for Uro-Lieve, highlighted the pressing clinical needs his project addresses while advocating for increased focus on women’s pain in medical research. The ERC PoC grants thus contribute to both enhancing research and supporting societal improvements, aligning with the objectives of Horizon Europe, the EU's overarching research and innovation framework.